ERS International Congress, Milan 2017

Browse by day:
Saturday, 09.09.2017
Sunday, 10.09.2017
Monday, 11.09.2017
Tuesday, 12.09.2017
Wednesday, 13.09.2017

 

Sponsored symposia:

Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.


The many faces of sarcoidosis

Poster Discussion
Chairs: A. Prasse (Hannover, Germany), D. Culver (Cleveland, United States of America)
Late Breaking Abstract - Promising results of the infliximab biosimilar Inflectra® in severe sarcoidosis patients
M. Schimmelpennink (Nieuwegein, Netherlands)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
I. Merenkova (Kyiv, Ukraine)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Malondialdehyde and nitrotyrosine as markers of peroxynitrite activity in sarcoidosis
A. Dubaniewicz (Gdansk, Poland)
Congress or journal article abstract
Congress or journal article abstract
Outcome predictive factors in patients with sarcoidosis
D. Calaras (Chisinau, Republic of Moldova)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
In situ analysis by SEM-EDX spectroscopy of 10 sarcoidosis cases from MINASARC study
M. Catinon (Villeurbanne, France)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Neurological signs in patients with sarcoidosis - is it neurosarcoidosis?
A. Kempisty (Warszawa, Poland)
Congress or journal article abstract
Congress or journal article abstract
Fatigue perception and related factors in patients with advanced sarcoidosis and COPD patients
S. Ozalevli (Izmir, Turkey)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
The role of HLA-DRB1* alleles in prediction of long term prognosis in sarcoidosis
E. Özyilmaz (Adana, Turkey)
Congress or journal article abstract
Congress or journal article abstract
The frequency of etarnecept related sarcoidosis
E. Özyilmaz (Adana, Turkey)
Congress or journal article abstract
Congress or journal article abstract
Posaconazole in vitro action on peripheral blood mononuclear cells from sarcoidosis patients
M. Tercelj-Zorman (Ljubljana, Slovenia)
Congress or journal article abstract
Congress or journal article abstract
Sarcoidosis and neoplasm, a coincidence?
A. Goljan Geremek (Warszawa, Poland)
Congress or journal article abstract
Congress or journal article abstract
Gender based differences in radiation-induced lung injury in rats
F. Kanat (Konya, Turkey)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
The granulomas morphology and clinical picture of sarcoidosis.
O. Denisova (Tomsk, Russian Federation)
Congress or journal article abstract
Congress or journal article abstract
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity
P. Cameli (Certaldo, Italy)
Congress or journal article abstract
Congress or journal article abstract
The role of 18-FDG PET/CT in lung sarcoidosis
Z. Pavlovic-Popovic (Sremska Kamenica, Republic of Serbia)
Congress or journal article abstract
Congress or journal article abstract
Functional and symptomatic burden of small fiber neuropathy in sarcoidosis.
D. Culver (Cleveland, United States of America)
Congress or journal article abstract
Congress or journal article abstract
Interleukin-2 and C-reactive protein in assessing the effectiveness of pulmonary sarcoidosis treatment
K. Shvets (Ivano-Frankivsk, Ukraine)
Congress or journal article abstract
Congress or journal article abstract
Evaluation of Impulse Oscillometry in patients with SarcoidosisEvaluation of Impulse Oscillometry system in patients with pulmonary Sarcoidosis
A. Talwar (Noida (Uttar Pradesh), India)
Congress or journal article abstract
Congress or journal article abstract